Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning.

Adolescent Alemtuzumab Antibodies, Monoclonal/pharmacology Antibodies, Monoclonal, Humanized Antibodies, Neoplasm/pharmacology Antilymphocyte Serum/administration & dosage Antineoplastic Combined Chemotherapy Protocols/therapeutic use Busulfan/administration & dosage Combined Modality Therapy Disease-Free Survival Female Graft vs Host Disease/epidemiology,etiology Graft vs Leukemia Effect Hematopoietic Stem Cell Transplantation/statistics & numerical data Humans Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy,surgery Lymphocyte Depletion Lymphocyte Transfusion Male Middle Aged Survival Rate Transplantation Conditioning/methods Transplantation, Homologous Vidarabine/administration & dosage,analogs & derivatives

Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Antilymphocyte Serum Alemtuzumab Vidarabine Busulfan fludarabine